Rhaeos, Inc.
15
6
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
13.3%
2 terminated/withdrawn out of 15 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
50%
2 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
Role: collaborator
Flow Detection in Open and Closed Shunt Valve Periods
Role: lead
Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device
Role: lead
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
Role: lead
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
Role: lead
Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
Role: lead
Assessment of Flow in Cerebrospinal Fluid Shunts With a Second Generation Wireless Thermal Anisotropy Measurement Device
Role: lead
Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices
Role: lead
Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device
Role: lead
Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device in Asymptomatic Patients
Role: lead
Formative Usability Assessment of Wireless Thermal Anisotropy Devices
Role: lead
Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device
Role: lead
Assessment of CSF Shunt Flow With Thermal Measurements B
Role: lead
Assessment of CSF Shunt Flow in an Outpatient Setting with a Thermal Measurement Device
Role: lead
Assessment of CSF Shunt Flow With Thermal Measurements A
Role: lead
All 15 trials loaded